1-8 of 8
Ying Han
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice

Free
Xiaodong Sun, Fang Han, Qingguo Lu, Xuan Li, Di Ren, Jingwen Zhang, Ying Han, Yang K. Xiang, Ji Li
Journal: Diabetes
Diabetes 2020;69(6):1292–1305
https://doi.org/10.2337/db19-0991
Published: 31 March 2020
View article titled, Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice
Open the PDF for Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice in another window
Meeting Abstracts

Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes—A Real-World Study (China PDS)

Free
YING HAN, LIXIAN CHEN, DAQING HU, HUI JIN, NAILONG YANG, XIAOYUN SHI, QUANMIN LI, LINLANG LIANG, LI ZANG, MINGMING LIU, JAMES HE, YIMING MU
Journal: Diabetes
Diabetes 2018;67(Supplement_1):2266-PUB
https://doi.org/10.2337/db18-2266-PUB
Published: 01 July 2018
View article titled, Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes—A Real-World Study (China PDS)
Meeting Abstracts

Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline HbA1c Patients with Type 2 Diabetes—A Real-World Study (China PDS)

Free
DAQING HU, YING HAN, LIXIAN CHEN, HUI JIN, NAILONG YANG, XIAOYUN SHI, QUANMIN LI, LINLANG LIANG, LI ZANG, MINGMING LIU, JAMES HE, YIMING MU
Journal: Diabetes
Diabetes 2018;67(Supplement_1):929-P
https://doi.org/10.2337/db18-929-P
Published: 01 July 2018
View article titled, Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline HbA1c Patients with Type 2 Diabetes—A Real-World Study (China PDS)
Meeting Abstracts

Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes—A Real-World Study (China PDS)

Free
LIXIAN CHEN, YING HAN, DAQING HU, HUI JIN, NAILONG YANG, XIAOYUN SHI, QUANMIN LI, LINLANG LIANG, LI ZANG, MINGMING LIU, JAMES HE, YIMING MU
Journal: Diabetes
Diabetes 2018;67(Supplement_1):2267-PUB
https://doi.org/10.2337/db18-2267-PUB
Published: 01 July 2018
View article titled, Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes—A Real-World Study (China PDS)
Meeting Abstracts

Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Agents in Different Regional Patients with Type 2 Diabetes—A Real-World Study (China PDS)

Free
LI ZANG, YING HAN, LIXIAN CHEN, DAQING HU, HUI JIN, NAILONG YANG, XIAOYUN SHI, QUANMIN LI, LINLANG LIANG, MINGMING LIU, JAMES HE, YIMING MU
Journal: Diabetes
Diabetes 2018;67(Supplement_1):2268-PUB
https://doi.org/10.2337/db18-2268-PUB
Published: 01 July 2018
View article titled, Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Agents in Different Regional Patients with Type 2 Diabetes—A Real-World Study (China PDS)
Meeting Abstracts

Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline BMI Patients with Type 2 Diabetes—A Real-World Study (China PDS)

Free
HUI JIN, YING HAN, LIXIAN CHEN, DAQING HU, NAILONG YANG, XIAOYUN SHI, QUANMIN LI, LINLANG LIANG, LI ZANG, MINGMING LIU, JAMES HE, YIMING MU
Journal: Diabetes
Diabetes 2018;67(Supplement_1):2307-PUB
https://doi.org/10.2337/db18-2307-PUB
Published: 01 July 2018
View article titled, Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline BMI Patients with Type 2 Diabetes—A Real-World Study (China PDS)
Journal Articles

HLA-B*07, HLA-DRB1*07, HLA-DRB1*12, and HLA-C*03:02 Strongly Associate With BMI: Data From 1.3 Million Healthy Chinese Adults

Free
Jie Shen, Tingwei Guo, Tao Wang, Yisong Zhen, Xiao Ma, Yuan Wang, Zhi-Xin Zhang, Jian-Ping Cai, Wei Mao, Fa-Ming Zhu, Jian-Ping Li, Zhen-Lei Wang, De-Mei Zhang, Meng-Li Liu, Xiao-Yan Shan, Bo-Wei Zhang, Chuan-Fu Zhu, Zhi-Hui Deng, Wei-Jian Yu, Qiang Chen, Guo-Liang Li, Tao Yang, Shan Lu, Qin-Qin Pan, Su Fan, Xiao-Yan Wang, Xing Zhao, Xin-Yun Bi, Yan-Hui Qiao, Pin-Can Su, Rong Lv, Guo-Ying Li, Heng-Cong Li, Bin Pei, Li-Xin Jiao, Gang Shen, Jie Liu, Zhi-Hui Feng, Yu-Ping Su, Yu-Bin Xie, Wen-Ying Di, Xin-Yu Wang, Xiang Liu, Xiao-Ping Zhang, Dan Du, Qi Liu, Ying Han, Jia-Wei Chen, Min Gu, Leslie J. Baier
Journal: Diabetes
Diabetes 2018;67(5):861–871
https://doi.org/10.2337/db17-0852
Published: 26 February 2018
View article titled, HLA-B*07, HLA-DRB1*07, HLA-DRB1*12, and HLA-C*03:02 Strongly Associate With BMI: Data From 1.3 Million Healthy Chinese Adults
Open the PDF for HLA-B*07, HLA-DRB1*07, HLA-DRB1*12, and HLA-C*03:02 Strongly Associate With BMI: Data From 1.3 Million Healthy Chinese Adults in another window
Includes: Supplementary data
Journal Articles

FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice

Free
Tong-Yan Liu, Xiao-Qing Xiong, Xing-Sheng Ren, Ming-Xia Zhao, Chang-Xiang Shi, Jue-Jin Wang, Ye-Bo Zhou, Feng Zhang, Ying Han, Xing-Ya Gao, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu
Journal: Diabetes
Diabetes 2016;65(11):3262–3275
https://doi.org/10.2337/db16-0356
Published: 08 August 2016
View article titled, FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice
Open the PDF for FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice in another window
Includes: Supplementary data